GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aleafia Health Inc (OTCPK:ALEAF) » Definitions » Cyclically Adjusted Price-to-FCF

Aleafia Health (Aleafia Health) Cyclically Adjusted Price-to-FCF : (As of May. 05, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Aleafia Health Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Aleafia Health Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Aleafia Health's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aleafia Health Cyclically Adjusted Price-to-FCF Chart

Aleafia Health Annual Data
Trend Jan12 Jan13 Jan14 Jan15 Jan16 Oct17 Dec18 Dec19 Dec20 Mar23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Aleafia Health Quarterly Data
Oct17 Jan18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aleafia Health's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Aleafia Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aleafia Health's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aleafia Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Aleafia Health's Cyclically Adjusted Price-to-FCF falls into.



Aleafia Health Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Aleafia Health's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, Aleafia Health's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.003/122.7021*122.7021
=-0.003

Current CPI (Mar. 2023) = 122.7021.

Aleafia Health Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201210 -0.014 96.550 -0.018
201301 -0.001 95.839 -0.001
201304 0.000 96.945 0.000
201307 0.001 97.261 0.001
201310 -0.001 97.182 -0.001
201401 0.000 97.261 0.000
201404 0.000 98.920 0.000
201407 -0.012 99.315 -0.015
201410 -0.001 99.473 -0.001
201501 -0.003 98.209 -0.004
201504 -0.003 99.710 -0.004
201507 -0.010 100.579 -0.012
201510 0.000 100.500 0.000
201601 -0.001 100.184 -0.001
201604 -0.020 101.370 -0.024
201607 -0.002 101.844 -0.002
201610 -0.005 102.002 -0.006
201701 -0.037 102.318 -0.044
201704 -0.012 103.029 -0.014
201707 -0.011 103.029 -0.013
201710 0.003 103.424 0.004
201801 0.004 104.056 0.005
201806 -0.007 105.557 -0.008
201809 -0.071 105.636 -0.082
201812 -0.033 105.399 -0.038
201903 -0.066 106.979 -0.076
201906 -0.039 107.690 -0.044
201909 -0.038 107.611 -0.043
201912 -0.039 107.769 -0.044
202003 -0.020 107.927 -0.023
202006 -0.001 108.401 -0.001
202009 -0.026 108.164 -0.029
202012 -0.018 108.559 -0.020
202103 -0.025 110.298 -0.028
202106 -0.008 111.720 -0.009
202109 -0.047 112.905 -0.051
202206 -0.004 120.806 -0.004
202209 -0.004 120.648 -0.004
202212 0.001 120.964 0.001
202303 -0.003 122.702 -0.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Aleafia Health  (OTCPK:ALEAF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Aleafia Health Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Aleafia Health's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Aleafia Health (Aleafia Health) Business Description

Traded in Other Exchanges
N/A
Address
85 Basaltic Road, Concord, ON, CAN, L4K 1G4
Aleafia Health Inc is a vertically integrated cannabis health and wellness company which owns three cannabis product and cultivation facilities where it produces a diverse portfolio of commercially high-margin derivative products including oils, capsules and sprays. The company operates national network of medical cannabis clinics and has seen over 60,000 patients to date.